221 related articles for article (PubMed ID: 17088901)
1. Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification.
Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H
Br J Cancer; 2006 Dec; 95(11):1562-7. PubMed ID: 17088901
[TBL] [Abstract][Full Text] [Related]
2. Loss of Smad4 protein expression and 18qLOH as molecular markers indicating lymph node metastasis in colorectal cancer--a study matched for tumor depth and pathology.
Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H
J Surg Oncol; 2008 Jan; 97(1):69-73. PubMed ID: 17786972
[TBL] [Abstract][Full Text] [Related]
3. SMAD4 as a prognostic marker in colorectal cancer.
Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
[TBL] [Abstract][Full Text] [Related]
4. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 18q deletion as a novel molecular predictor for colorectal cancer with simultaneous hepatic metastasis.
Tanaka T; Watanabe T; Kitayama J; Kanazawa T; Kazama Y; Tanaka J; Kazama S; Nagawa H
Diagn Mol Pathol; 2009 Dec; 18(4):219-25. PubMed ID: 19861895
[TBL] [Abstract][Full Text] [Related]
6. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
7. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
[TBL] [Abstract][Full Text] [Related]
8. No SMAD4 hypermethylation in colorectal cancer.
Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of Smad4 in gastric carcinomas.
Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW
Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080
[TBL] [Abstract][Full Text] [Related]
10. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
11. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
12. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis.
Miyaki M; Iijima T; Konishi M; Sakai K; Ishii A; Yasuno M; Hishima T; Koike M; Shitara N; Iwama T; Utsunomiya J; Kuroki T; Mori T
Oncogene; 1999 May; 18(20):3098-103. PubMed ID: 10340381
[TBL] [Abstract][Full Text] [Related]
13. Expression of Smad4 and TGF-beta2 in colorectal carcinoma.
Kouvidou Ch; Latoufis C; Lianou E; Kouvatseas G; Kakouri E; Anagnostakis D; Vrettou-Aravani V; Betsi E; Karatapanis S
Anticancer Res; 2006; 26(4B):2901-7. PubMed ID: 16886611
[TBL] [Abstract][Full Text] [Related]
14. SMAD4/DPC4 expression and prognosis in human colorectal cancer.
Isaksson-Mettävainio M; Palmqvist R; Forssell J; Stenling R; Oberg A
Anticancer Res; 2006; 26(1B):507-10. PubMed ID: 16739311
[TBL] [Abstract][Full Text] [Related]
15. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene.
Bläker H; von Herbay A; Penzel R; Gross S; Otto HF
Oncogene; 2002 Jan; 21(1):158-64. PubMed ID: 11791187
[TBL] [Abstract][Full Text] [Related]
16. Allelic status of chromosomes 17p, 18q, 22q [corrected] 3p and their clinical usefulness in colorectal cancer.
Fujita S; Baba H; Yamamoto S; Akasu T; Moriya Y; Sugano K
Anticancer Res; 2006; 26(4B):2833-40. PubMed ID: 16886602
[TBL] [Abstract][Full Text] [Related]
17. SMAD4 levels and response to 5-fluorouracil in colorectal cancer.
Alhopuro P; Alazzouzi H; Sammalkorpi H; Dávalos V; Salovaara R; Hemminki A; Järvinen H; Mecklin JP; Schwartz S; Aaltonen LA; Arango D
Clin Cancer Res; 2005 Sep; 11(17):6311-6. PubMed ID: 16144935
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
19. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas.
MacGrogan D; Pegram M; Slamon D; Bookstein R
Oncogene; 1997 Aug; 15(9):1111-4. PubMed ID: 9285566
[TBL] [Abstract][Full Text] [Related]
20. [Deletion mapping of chromosome 18q and Smad proteins expression analysis in urinary bladder carcinomas].
Fan Z; Zhang J; Bai J
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):135-7. PubMed ID: 11783019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
